Quest Diagnostics Incorporated DGX
- Market cap
- $26.2B
- P/E
- 24.8×
Follow DGX
Quest Diagnostics Incorporated (DGX) Return on invested capital
Quest Diagnostics Incorporated's return on invested capital over the twelve months to 30 June 2026 was 7.94%, up 0.1 percentage points from fiscal 2025 (7.81%). Over the past ten years it has ranged from 6.74% (fiscal 2024) to 15.5% (fiscal 2021); the current reading is higher than 36% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Annual
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 7.81% | 1.07 |
| FY2024 | 6.74% | (0.87) |
| FY2023 | 7.61% | (1.69) |
| FY2022 | 9.30% | (6.16) |
| FY2021 | 15.5% | 2.72 |
| FY2020 | 12.7% | 4.44 |
| FY2019 | 8.30% | 0.68 |
| FY2018 | 7.62% | (0.84) |
| FY2017 | 8.46% | (1.47) |
| FY2016 | 9.93% | (0.69) |
Against its own ten years
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 48.9% |
| MTD Mettler-Toledo International, Inc. compare | 35.4% |
| ILMN Illumina, Inc. compare | 17.5% |
| DGX Quest Diagnostics Incorporated | 7.94% |
| LH Labcorp Holdings Inc. compare | 6.50% |
| RVTY Revvity Inc. compare | 2.38% |
| WAT Waters Corporation compare | 1.05% |
| MEDP Medpace Holdings, Inc. compare | 0.00% |
| GH Guardant Health, Inc. compare | −129.7% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on DGX
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement